结节慢性淋巴细胞白血病结肠外结节受累。

IF 10.1 1区 医学 Q1 HEMATOLOGY American Journal of Hematology Pub Date : 2024-08-28 DOI:10.1002/ajh.27467
Michael Keith Alister Zimmerman, Lindsay Wilde
{"title":"结节慢性淋巴细胞白血病结肠外结节受累。","authors":"Michael Keith Alister Zimmerman,&nbsp;Lindsay Wilde","doi":"10.1002/ajh.27467","DOIUrl":null,"url":null,"abstract":"<p>A 64-year-old male patient with a known diagnosis of chronic lymphocytic leukemia (CLL) was referred to the gastroenterology department for a follow-up colonoscopy. A previous routine colonoscopy 4 years prior found benign polyps in the colon, and the patient was recommended to have a repeat colonoscopy within 3 years. In the interim, the patient had no new gastrointestinal symptoms. However, he was diagnosed with CLL based on flow cytometry approximately 1 year after his first colonoscopy. At diagnosis, his CLL was Rai Stage 1, and he did not meet any criteria for treatment initiation.</p><p>The repeat colonoscopy was notable for continuous diffuse nodularity without bleeding throughout the colon from the cecum to the rectum, with only relative sparing of the transverse colon as seen in Image 1. Multiple cold forceps biopsies were obtained of nodularities in the cecum/ascending colon, transverse colon, descending colon, and rectum. The biopsies were sent for histology to evaluate for suspected lymphoid aggregates but also to rule out polyposis syndrome. Histology showed submucosal atypical lymphoid infiltrate present as expansile nodules. The lymphocytes were small in size with dense chromatin and scant cytoplasm. Immunohistochemistry was diffusely positive for CD5, CD20, and CD23, and negative for BCL-1. Scattered reactive T cells were positive for CD3. P53 was wild-type. Ki-67 showed a variable proliferation rate of 10%–30%. All colonic biopsies showed similar findings consistent with the patient's known CLL.</p><p>Despite these striking incidental clinical findings, the patient remains asymptomatic without cytopenias or constitutional symptoms. On exam he has stable supraclavicular lymphadenopathy with a palpable lymph node measuring approximately 3 cm in diameter that is non-tender and mobile. His white blood cell count is relatively stable, fluctuating between 18 and 43 × 10<sup>9</sup>/L. Other routine lab work, including renal function and hepatic function, also all remain stable. No additional imaging studies have yet been performed. Therefore, the decision was made to continue clinically monitoring this patient without initiating treatment, as per standard of care.<span><sup>1</sup></span></p><p>Extranodal involvement of CLL presenting as nodularity has been described in several organs, including the skin,<span><sup>2</sup></span> kidneys,<span><sup>3</sup></span> and cardiac valves.<span><sup>4</sup></span> Gastrointestinal manifestations of CLL are rare. One report of extranodal involvement in the gastrointestinal tract described a patient who had a positive fecal test for occult blood prompting colonoscopy, which showed a normal-appearing colon but with CLL involvement on histology of biopsies.<span><sup>5</sup></span> Another reported on a single 6 mm polyp in the ascending colon revealing intestinal infiltration of CLL on biopsy.<span><sup>6</sup></span> To our knowledge, this is the first report of diffuse nodularity resulting from intestinal infiltration of CLL.</p><p>The authors declare no conflicts of interest.</p>","PeriodicalId":7724,"journal":{"name":"American Journal of Hematology","volume":"100 2","pages":"298-299"},"PeriodicalIF":10.1000,"publicationDate":"2024-08-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705211/pdf/","citationCount":"0","resultStr":"{\"title\":\"Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon\",\"authors\":\"Michael Keith Alister Zimmerman,&nbsp;Lindsay Wilde\",\"doi\":\"10.1002/ajh.27467\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p>A 64-year-old male patient with a known diagnosis of chronic lymphocytic leukemia (CLL) was referred to the gastroenterology department for a follow-up colonoscopy. A previous routine colonoscopy 4 years prior found benign polyps in the colon, and the patient was recommended to have a repeat colonoscopy within 3 years. In the interim, the patient had no new gastrointestinal symptoms. However, he was diagnosed with CLL based on flow cytometry approximately 1 year after his first colonoscopy. At diagnosis, his CLL was Rai Stage 1, and he did not meet any criteria for treatment initiation.</p><p>The repeat colonoscopy was notable for continuous diffuse nodularity without bleeding throughout the colon from the cecum to the rectum, with only relative sparing of the transverse colon as seen in Image 1. Multiple cold forceps biopsies were obtained of nodularities in the cecum/ascending colon, transverse colon, descending colon, and rectum. The biopsies were sent for histology to evaluate for suspected lymphoid aggregates but also to rule out polyposis syndrome. Histology showed submucosal atypical lymphoid infiltrate present as expansile nodules. The lymphocytes were small in size with dense chromatin and scant cytoplasm. Immunohistochemistry was diffusely positive for CD5, CD20, and CD23, and negative for BCL-1. Scattered reactive T cells were positive for CD3. P53 was wild-type. Ki-67 showed a variable proliferation rate of 10%–30%. All colonic biopsies showed similar findings consistent with the patient's known CLL.</p><p>Despite these striking incidental clinical findings, the patient remains asymptomatic without cytopenias or constitutional symptoms. On exam he has stable supraclavicular lymphadenopathy with a palpable lymph node measuring approximately 3 cm in diameter that is non-tender and mobile. His white blood cell count is relatively stable, fluctuating between 18 and 43 × 10<sup>9</sup>/L. Other routine lab work, including renal function and hepatic function, also all remain stable. No additional imaging studies have yet been performed. Therefore, the decision was made to continue clinically monitoring this patient without initiating treatment, as per standard of care.<span><sup>1</sup></span></p><p>Extranodal involvement of CLL presenting as nodularity has been described in several organs, including the skin,<span><sup>2</sup></span> kidneys,<span><sup>3</sup></span> and cardiac valves.<span><sup>4</sup></span> Gastrointestinal manifestations of CLL are rare. One report of extranodal involvement in the gastrointestinal tract described a patient who had a positive fecal test for occult blood prompting colonoscopy, which showed a normal-appearing colon but with CLL involvement on histology of biopsies.<span><sup>5</sup></span> Another reported on a single 6 mm polyp in the ascending colon revealing intestinal infiltration of CLL on biopsy.<span><sup>6</sup></span> To our knowledge, this is the first report of diffuse nodularity resulting from intestinal infiltration of CLL.</p><p>The authors declare no conflicts of interest.</p>\",\"PeriodicalId\":7724,\"journal\":{\"name\":\"American Journal of Hematology\",\"volume\":\"100 2\",\"pages\":\"298-299\"},\"PeriodicalIF\":10.1000,\"publicationDate\":\"2024-08-28\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11705211/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"American Journal of Hematology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://onlinelibrary.wiley.com/doi/10.1002/ajh.27467\",\"RegionNum\":1,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"HEMATOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"American Journal of Hematology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1002/ajh.27467","RegionNum":1,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"HEMATOLOGY","Score":null,"Total":0}
引用次数: 0

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Oh node: Extranodal nodular involvement of chronic lymphocytic leukemia in the colon

A 64-year-old male patient with a known diagnosis of chronic lymphocytic leukemia (CLL) was referred to the gastroenterology department for a follow-up colonoscopy. A previous routine colonoscopy 4 years prior found benign polyps in the colon, and the patient was recommended to have a repeat colonoscopy within 3 years. In the interim, the patient had no new gastrointestinal symptoms. However, he was diagnosed with CLL based on flow cytometry approximately 1 year after his first colonoscopy. At diagnosis, his CLL was Rai Stage 1, and he did not meet any criteria for treatment initiation.

The repeat colonoscopy was notable for continuous diffuse nodularity without bleeding throughout the colon from the cecum to the rectum, with only relative sparing of the transverse colon as seen in Image 1. Multiple cold forceps biopsies were obtained of nodularities in the cecum/ascending colon, transverse colon, descending colon, and rectum. The biopsies were sent for histology to evaluate for suspected lymphoid aggregates but also to rule out polyposis syndrome. Histology showed submucosal atypical lymphoid infiltrate present as expansile nodules. The lymphocytes were small in size with dense chromatin and scant cytoplasm. Immunohistochemistry was diffusely positive for CD5, CD20, and CD23, and negative for BCL-1. Scattered reactive T cells were positive for CD3. P53 was wild-type. Ki-67 showed a variable proliferation rate of 10%–30%. All colonic biopsies showed similar findings consistent with the patient's known CLL.

Despite these striking incidental clinical findings, the patient remains asymptomatic without cytopenias or constitutional symptoms. On exam he has stable supraclavicular lymphadenopathy with a palpable lymph node measuring approximately 3 cm in diameter that is non-tender and mobile. His white blood cell count is relatively stable, fluctuating between 18 and 43 × 109/L. Other routine lab work, including renal function and hepatic function, also all remain stable. No additional imaging studies have yet been performed. Therefore, the decision was made to continue clinically monitoring this patient without initiating treatment, as per standard of care.1

Extranodal involvement of CLL presenting as nodularity has been described in several organs, including the skin,2 kidneys,3 and cardiac valves.4 Gastrointestinal manifestations of CLL are rare. One report of extranodal involvement in the gastrointestinal tract described a patient who had a positive fecal test for occult blood prompting colonoscopy, which showed a normal-appearing colon but with CLL involvement on histology of biopsies.5 Another reported on a single 6 mm polyp in the ascending colon revealing intestinal infiltration of CLL on biopsy.6 To our knowledge, this is the first report of diffuse nodularity resulting from intestinal infiltration of CLL.

The authors declare no conflicts of interest.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
CiteScore
15.70
自引率
3.90%
发文量
363
审稿时长
3-6 weeks
期刊介绍: The American Journal of Hematology offers extensive coverage of experimental and clinical aspects of blood diseases in humans and animal models. The journal publishes original contributions in both non-malignant and malignant hematological diseases, encompassing clinical and basic studies in areas such as hemostasis, thrombosis, immunology, blood banking, and stem cell biology. Clinical translational reports highlighting innovative therapeutic approaches for the diagnosis and treatment of hematological diseases are actively encouraged.The American Journal of Hematology features regular original laboratory and clinical research articles, brief research reports, critical reviews, images in hematology, as well as letters and correspondence.
期刊最新文献
Issue Information Frontline Therapy of AML in the Fit and Younger Population—Incorporating Molecularly Targeted Agents Maintenance Therapy in AML: What Is the Future Potential? Treatment of Relapsed/Refractory AML—Novel Treatment Options Including Immunotherapy Therapeutic Advances and Future of Therapy in Acute Myeloid Leukemia
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1